| Ms Jacqueline M Tang-morgan, PHD | |
|
131 Sanders Ferry Rd Ste 203, Hendersonville, TN 37075-3662 | |
| (615) 822-1222 | |
| (615) 822-8306 |
| Full Name | Ms Jacqueline M Tang-morgan |
|---|---|
| Gender | Female |
| Speciality | Clinical Psychologist |
| Experience | 22 Years |
| Location | 131 Sanders Ferry Rd Ste 203, Hendersonville, Tennessee |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1649491010 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | 2646 (Tennessee) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hughes Mcdaniel And Associates Plc | 9133195936 | 3 |
News Archive
RegeneRx Biopharmaceuticals, Inc. today announced the results of its first non-clinical dry eye study using RGN-259, RegeneRx's ophthalmic, preservative-free eye drop for the treatment of Dry Eye Syndrome (DES). In the study, animals were treated with RGN-259, a vehicle control and a positive control, doxycycline.
Many physicians may be missing the chance to talk to obese children and their parents about ways to control the children's weight, according to Saint Louis University research reported in Pediatrics.
Researchers at the National Center for Advancing Translational Sciences, part of the National Institutes of Health, have developed a system to accelerate the discovery of chemical compounds that inhibit an enzyme implicated in a number of cancers.
University of Arizona Health Sciences researchers recently completed a study that has the potential to improve cancer treatment for colorectal cancer and melanoma by using nanotechnology to deliver chemotherapy in a way that makes it more effective against aggressive tumors.
› Verified 1 days ago
| Entity Name | Hughes Mcdaniel & Associates Plc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508967423 PECOS PAC ID: 9133195936 Enrollment ID: O20040902001170 |
News Archive
RegeneRx Biopharmaceuticals, Inc. today announced the results of its first non-clinical dry eye study using RGN-259, RegeneRx's ophthalmic, preservative-free eye drop for the treatment of Dry Eye Syndrome (DES). In the study, animals were treated with RGN-259, a vehicle control and a positive control, doxycycline.
Many physicians may be missing the chance to talk to obese children and their parents about ways to control the children's weight, according to Saint Louis University research reported in Pediatrics.
Researchers at the National Center for Advancing Translational Sciences, part of the National Institutes of Health, have developed a system to accelerate the discovery of chemical compounds that inhibit an enzyme implicated in a number of cancers.
University of Arizona Health Sciences researchers recently completed a study that has the potential to improve cancer treatment for colorectal cancer and melanoma by using nanotechnology to deliver chemotherapy in a way that makes it more effective against aggressive tumors.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ms Jacqueline M Tang-morgan, PHD Po Box 1155, Hendersonville, TN 37077-1155 Ph: (615) 822-1222 | Ms Jacqueline M Tang-morgan, PHD 131 Sanders Ferry Rd Ste 203, Hendersonville, TN 37075-3662 Ph: (615) 822-1222 |
News Archive
RegeneRx Biopharmaceuticals, Inc. today announced the results of its first non-clinical dry eye study using RGN-259, RegeneRx's ophthalmic, preservative-free eye drop for the treatment of Dry Eye Syndrome (DES). In the study, animals were treated with RGN-259, a vehicle control and a positive control, doxycycline.
Many physicians may be missing the chance to talk to obese children and their parents about ways to control the children's weight, according to Saint Louis University research reported in Pediatrics.
Researchers at the National Center for Advancing Translational Sciences, part of the National Institutes of Health, have developed a system to accelerate the discovery of chemical compounds that inhibit an enzyme implicated in a number of cancers.
University of Arizona Health Sciences researchers recently completed a study that has the potential to improve cancer treatment for colorectal cancer and melanoma by using nanotechnology to deliver chemotherapy in a way that makes it more effective against aggressive tumors.
› Verified 1 days ago
Dr. Peter Franklin Wilson, ED.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 105 Music Village Blvd, Hendersonville, TN 37075 Phone: 615-824-3772 | |
Dr. Rosemary Kehoe Peacher, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 394 W Main St, Suite B9, Hendersonville, TN 37075 Phone: 615-826-0347 Fax: 615-826-9147 | |
Mr. James L Hughes, PH.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 131 Sanders Ferry Rd Ste 203, Hendersonville, TN 37075 Phone: 615-822-1222 Fax: 615-822-8306 | |
Wanda J. Rice, EDS., MBA Psychologist Medicare: Not Enrolled in Medicare Practice Location: 130 Hunters Trail, Hendersonville, TN 37075 Phone: 615-715-4947 | |
Dr. Rhonda Lee D'imperio, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 105 Music Village Blvd, Babbcenter, Hendersonville, TN 37075 Phone: 614-824-3772 Fax: 615-447-1065 | |
Linda Marie Leftwich, PH.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 509 Jones Ln, Hendersonville, TN 37075 Phone: 615-822-9170 Fax: 615-822-9997 |